Abbott’s $14.7 Billion Bond Set to Be Biggest in U.S. Since 2009

Abbott Laboratories (ABT) is planning to sell $14.7 billion of bonds in the largest dollar-denominated offering in more than three years as the drug and medical-device maker prepares to split in two.

Through its AbbVie Inc. pharmaceutical unit, Abbott may sell bonds in six parts ranging in size from $500 million to $4 billion, according to a person familiar with the transaction.

The offering is the largest dollar-denominated sale since February 2009, when Roche Holding AG issued $16 billion of debt, Bloomberg data show.

To contact the reporter on this story: Sarika Gangar at sgangar@bloomberg.net

To contact the editor responsible for this story: John Parry at jparry5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.